Pressure BioSciences, Inc. Discusses Research Market, Goals

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Topicus.com Inc. Achieves Record Financial Results in Q3 2024 Today, Topicus.com Inc. (TSXV: TOI) has shared promising financial data for the third quarter of 2024, indicating a strong upward trajectory in both revenue and profits. This positive news reflects a robust business performance managed under the guidance of Constellation Software Inc. (TSX: CSU). All figures...

Rumble Stock Experiences Notable Increase Rumble has recently witnessed a remarkable surge in its shares, jumping by as much as 17%. This increase represents the most significant intraday rise seen since July, attributed to an exciting partnership with gaming sensation Dr Disrespect. Exclusive Streaming Agreement with Dr Disrespect Under the partnership, Dr Disrespect...

Understanding Michelin's Share Buyback Initiative Michelin, well-known for its premium tire products, has been actively engaging in share repurchase activities. This initiative is significant for any investor as it showcases the company's robust financial health and strategic approach to increasing shareholder value. By buying back its shares, Michelin signals confidence...

Treasury Yields Steady Ahead of Key Inflation Data Treasury rates are not changing much while the market waits for important inflation figures. Investor caution is high in the last week of June. They are delaying significant actions until the report on Friday. Slightly higher is the yield on the 10-year Treasury. Similar little gains are seen in the two-year yield. The...

MDPI's Innovations in Peer Review MDPI, a leading open access (OA) publisher, is transforming the peer review process with new technology. This initiative ties in seamlessly with the upcoming Peer Review Week 2024, which focuses on 'Innovation and Technology in Peer Review'. Set to take place at the end of September, this event aims to showcase the evolving world of...